ProPhase Labs, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q2 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2024 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q1 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q2 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q3 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q4 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
ProPhase Labs, Inc. Earnings Date And Information
ProPhase Labs, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.33 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0.25. The company had revenue of 3.15 M for the quarter and had revenue of 44.38 M for the year. ProPhase Labs, Inc. has generated $-1 earnings per share over the last year ($-0.98 diluted earnings per share) and currently has a price-to-earnings ratio of -0.54. ProPhase Labs, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
ProPhase Labs, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.35 | $2.82 M | $3.15 M | ||
| 08/14/2024 | Q2 2024 | -$0.08 | -$0.33 | -0.25 | $18.35 M | $2.47 M |
| 05/10/2024 | Q1 2024 | -$0.35 | $3.63 M | |||
| 12/29/2023 | Q4 2023 | -$0.48 | $3.50 M | |||
| 11/13/2023 | Q3 2023 | -$0.30 | $13.06 M | $8.37 M | ||
| 08/11/2023 | Q2 2023 | -$0.20 | $14.14 M | $13.22 M | ||
| 05/12/2023 | Q1 2023 | $0.03 | $19.30 M | |||
| 03/29/2023 | Q4 2022 | -$0.15 | $21.82 M | |||
| 11/10/2022 | Q3 2022 | $0.19 | $0.05 | -0.14 | $21.43 M | $24.20 M |
| 08/12/2022 | Q2 2022 | $0.40 | $20.01 M | $29.09 M | ||
| 05/13/2022 | Q1 2022 | $0.39 | $0.68 | 0.29 | $47.53 M | |
| 03/31/2022 | Q4 2021 | $0.42 | $45.16 M | |||
| 11/12/2021 | Q3 2021 | $0.07 | -$0.26 | -0.33 | $9.04 M | $9.47 M |
| 08/13/2021 | Q2 2021 | $0.19 | -$0.09 | -0.28 | $14.64 M | $9.14 M |
| 05/14/2021 | Q1 2021 | $0.07 | $15.27 M | |||
| 03/31/2021 | Q4 2020 | -$0.08 | $5.16 M | |||
| 11/19/2020 | Q3 2020 | -$0.04 | $3.84 M | |||
| 08/11/2020 | Q2 2020 | $0.01 | $3.62 M | |||
| 05/12/2020 | Q1 2020 | -$0.07 | $1.89 M | |||
| 03/26/2020 | Q4 2019 | -$0.04 | $3.14 M |
ProPhase Labs, Inc. Earnings: Frequently Asked Questions
-
When is ProPhase Labs, Inc.'s earnings date?
ProPhase Labs, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
How can I listen to ProPhase Labs, Inc.'s earnings conference call?
The conference call for ProPhase Labs, Inc.'s latest earnings report can be listened to online.
-
How can I read ProPhase Labs, Inc.'s conference call transcript?
The conference call transcript for ProPhase Labs, Inc.'s latest earnings report can be read online.
-
How much revenue does ProPhase Labs, Inc. generate each year?
ProPhase Labs, Inc. (:PRPH) has a recorded annual revenue of $44.38 M.
-
How much profit does ProPhase Labs, Inc. generate each year?
ProPhase Labs, Inc. (:PRPH) has a recorded net income of $44.38 M. ProPhase Labs, Inc. has generated $-0.98 earnings per share over the last four quarters.
-
What is ProPhase Labs, Inc.'s price-to-earnings ratio?
ProPhase Labs, Inc. (:PRPH) has a price-to-earnings ratio of -0.54 and price/earnings-to-growth ratio is 0.16.
